Patricia Simone Mora Villacorta, PA
Physician Assistant · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
Offices
2 locations · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Patricia Simone Mora Villacorta’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$53,999
Medicare paid this office $53,999 for 218 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 134 | $15,207 | $69 |
| Return visit (30+ min) | 94 | $11,658 | $96 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 20 | $10,091 | None |
| Aspiration and/or injection of fluid from large joint | 66 | $5,675 | $57 |
| New patient visit (30+ min) | 37 | $2,698 | $73 |
See all 7 services
| Short return visit (20+ min) | 134 | $15,207 | $69 |
| Return visit (30+ min) | 94 | $11,658 | $96 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 20 | $10,091 | None |
| Aspiration and/or injection of fluid from large joint | 66 | $5,675 | $57 |
| New patient visit (30+ min) | 37 | $2,698 | $73 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 22 | $299 | $13 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 59 | $245 | None |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Knee replacement | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Who their Medicare patients are
218 Original Medicare patients in 2024. Average age 76 · Women 64% · Also on Medicaid 10% · Health risk score 1.02. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Diabetes 27% · Chronic kidney disease 25% · Coronary heart disease 21% · Atrial fibrillation 17% · Depression 17% · Cancer 11% · COPD 10% · Heart failure 9% · Dementia 6% · Stroke 6%.
The office billed $360,141, Medicare allowed $72,654 and paid $53,999; for 2,520 services of 28 kinds; $11,197 of it was for drugs given in the office and $42,801 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 218 | 2,520 | 76 | 1.02 | $360,141 | $53,999 |
| 2023 | 204 | 1,869 | 76 | 0.95 | $208,777 | $45,146 |
| 2022 | 146 | 1,255 | 76 | 1.03 | $131,012 | $28,363 |
| 2021 | 90 | 400 | 76 | 1.00 | $65,371 | $14,655 |
| 2020 | 23 | 30 | 74 | 0.92 | $6,918 | $1,789 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Short return visit (20+ min) | 143 | $15,434 | $70 |
| Return visit (30+ min) | 72 | $8,557 | $97 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 16 | $8,289 | None |
| Aspiration and/or injection of fluid from large joint | 60 | $4,597 | $58 |
| New patient visit (30+ min) | 51 | $4,400 | $86 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 52 | $233 | None |
2022: 5 services
| Short return visit (20+ min) | 90 | $8,844 | $68 |
| Return visit (30+ min) | 39 | $4,015 | $98 |
| New patient visit (30+ min) | 48 | $3,959 | $82 |
| Aspiration and/or injection of fluid from large joint | 35 | $2,520 | $60 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 27 | $131 | None |
2021: 5 services
| Short return visit (20+ min) | 45 | $4,321 | $69 |
| Return visit (30+ min) | 32 | $3,597 | $100 |
| New patient visit (30+ min) | 27 | $2,060 | $76 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,394 | $50 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $28 | None |
Medicaid work
$1,520 in 2019
Medicaid paid $1,520 for 22 billed services this clinician did in 2019, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Global fee urgent care centers | 22 | $1,520 |
| 2019 | 22 | 1 | 22 | $1,520 |
Drugs they prescribed that Part D paid
$5,881
Pharmacies billed $5,881 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 29% of their Part D prescriptions (163 of 560) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
560 generic and 0 brand-name prescriptions · $5,881 in drug cost · 32 antibiotic prescriptions to 22 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Alendronate | 168 | $2,516 | $15 |
| Diclofenac | 42 | $849 | $20 |
| Hydrocodone-Acetaminophen | 109 | $719 | $7 |
| Diclofenac | 44 | $513 | $12 |
| Meloxicam | 83 | $378 | $5 |
See all 9 drugs
| Alendronate | 168 | $2,516 | $15 |
| Diclofenac | 42 | $849 | $20 |
| Hydrocodone-Acetaminophen | 109 | $719 | $7 |
| Diclofenac | 44 | $513 | $12 |
| Meloxicam | 83 | $378 | $5 |
| Oxycodone-Acetaminophen | 16 | $261 | $16 |
| Acetaminophen-Codeine | 19 | $76 | $4 |
| Tramadol | 17 | $64 | $4 |
| Amoxicillin | 19 | $18 | $1 |
Year by year
| 2024 | 560 | 225 | 29% (163) | 0% | $5,881 |
| 2023 | 721 | 237 | 21% (154) | None | $16,519 |
| 2022 | 444 | 198 | 27% (120) | None | $9,339 |
| 2021 | 308 | 148 | 29% (90) | None | $4,647 |
| 2020 | 115 | 71 | 25% (29) | None | $2,288 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Diclofenac | 95 | $5,169 | $54 |
| Alendronate | 217 | $4,027 | $19 |
| Celecoxib | 25 | $1,850 | $74 |
| Diclofenac | 34 | $1,167 | $34 |
| Hydrocodone-Acetaminophen | 110 | $983 | $9 |
| Meloxicam | 131 | $629 | $5 |
| Oxycodone-Acetaminophen | 12 | $98 | $8 |
| Tramadol | 16 | $51 | $3 |
| Acetaminophen-Codeine | 14 | $49 | $3 |
| Amoxicillin | 14 | $15 | $1 |
2022: 7 drugs
| Diclofenac | 36 | $1,911 | $53 |
| Alendronate | 111 | $1,432 | $13 |
| Diclofenac | 30 | $1,088 | $36 |
| Hydrocodone-Acetaminophen | 94 | $658 | $7 |
| Meloxicam | 95 | $368 | $4 |
| Amoxicillin | 12 | $36 | $3 |
| Tramadol | 17 | $35 | $2 |
2021: 6 drugs
| Diclofenac | 27 | $1,337 | $50 |
| Diclofenac | 14 | $636 | $45 |
| Hydrocodone-Acetaminophen | 61 | $485 | $8 |
| Alendronate | 41 | $396 | $10 |
| Meloxicam | 91 | $330 | $4 |
| Oxycodone-Acetaminophen | 17 | $125 | $7 |
2020: 3 drugs
| Diclofenac | 13 | $757 | $58 |
| Hydrocodone-Acetaminophen | 21 | $228 | $11 |
| Meloxicam | 40 | $176 | $4 |
Money from drug and device companies
$26 in 2025
| 2025 | 1 | 1 | None | $26 |
| 2022 | 3 | 8 | None | $168 |
| 2021 | 2 | 4 | None | $230 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Kyphon Express II Kyphopak Tray | $26 | 1 payment
|
See the published payment
| Medtronic | Education · 2025-05-28 | Kyphon Express II Kyphopak Tray | $26 |
See earlier years (2022, 2021)
2022: $168
| NuVasive | Lessray | $119 | 6 payments
|
| Pacira Pharmaceuticals | Iovera | $25 | 1 payment
|
| Orthofix Medical | Physio-Stim | $24 | 1 payment
|
2021: $230
| Ethicon | None | $210 | 3 payments
|
| Ethicon US | Stratafix | $20 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1497227573
- Licence
- CA PA56326
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 625 Lincoln Ave, San Jose, CA, 95126
- NPI first listed
- 2018-12-29
- NPI last updated
- 2024-07-18
- NPI record certified
- 2024-07-18
This is when the NPI record was last certified, not a medical board exam.